Welcome to eviQ
A free resource of evidence-based, consensus driven cancer treatment protocols and information for use at the point of care. eviQ is developed for the Australian context and supports health professionals in the delivery of cancer treatments.
The drug name Bacillus Calmette-Guerin (BCG) has been updated to Mycobacterium bovis (Bacillus Calmette and Guerin (BCG) strain)
Changes include advice which is more pragmatic for patients and carers in their home environment. The eviQ protocol recommendations remain unchanged for occupational exposure.
Expressions of interest are invited for the position of eviQ Medical Oncology Reference Committee Co-Chair. Click the link to find out details. EOIs close by COB Friday 20th July 2019.
New eviQ Education module.
This course presents information about the epidemiology, clinical manifestations and management principles of adult fever and neutropenia.